Two Sigma Investments, LP Bellus Health Inc. Transaction History

Two Sigma Investments, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.22 - $10.76 $95,302 - $124,751	11,594 Added 8.74%	144,194 $1.19 Million
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $864,569 - $1.16 Million	96,600 Added 268.33%	132,600 $1.4 Million
Q2 2022 Aug 15, 2022	BUY	$6.46 - $10.02 $232,560 - $360,720	36,000 New	36,000 $333,000
Q1 2022 May 16, 2022	SELL	$5.56 - $7.99 $427,563 - $614,431	-76,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.26 - $8.3 $404,494 - $638,270	76,900 New	76,900 $619,000
Q3 2020 Nov 16, 2020	SELL	$2.14 - $12.02 $105,288 - $591,384	-49,200 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.88 - $11.15 $436,896 - $548,580	49,200 New	49,200 $506,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.